HK Stock MarketDetailed Quotes

EVEREST MED (01952)

Watchlist
  • 39.920
  • +0.860+2.20%
Market Closed Jan 16 16:08 CST
14.11BMarket Cap-19.54P/E (TTM)

EVEREST MED (01952) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2025
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
Turnover
47.96%446.12M
461.16%706.68M
3,289.74%301.52M
884.46%125.93M
752.01%8.9M
23,588.89%12.79M
--1.04M
--54K
----
----
Operating income
47.96%446.12M
461.16%706.68M
3,289.74%301.52M
884.46%125.93M
752.01%8.9M
23,588.89%12.79M
1.04M
54K
Cost of sales
-108.31%-146.73M
-422.44%-179.79M
-2,022.91%-70.44M
-640.88%-34.41M
-811.54%-3.32M
-20,095.65%-4.65M
---364K
---23K
----
----
Operating expenses
-108.31%-146.73M
-422.44%-179.79M
-2,022.91%-70.44M
-640.88%-34.41M
-811.54%-3.32M
-20,095.65%-4.65M
-364K
-23K
Gross profit
29.56%299.4M
475.72%526.88M
4,043.43%231.08M
1,023.33%91.52M
720.15%5.58M
26,180.65%8.15M
680K
31K
Selling expenses
-57.07%-314.75M
-119.55%-508.07M
-212.48%-200.39M
29.16%-231.42M
56.72%-64.13M
-64.87%-326.69M
-251.94%-148.16M
-496.01%-198.15M
---42.1M
---33.25M
Administrative expenses
-27.35%-110.8M
-51.42%-250.08M
-4.65%-87M
40.28%-165.16M
30.09%-83.13M
-13.96%-276.55M
-10.69%-118.91M
12.65%-242.68M
---107.43M
-415.93%-277.83M
Research and development expenses
22.89%-195.22M
2.23%-528.04M
12.25%-253.16M
33.30%-540.05M
16.50%-288.49M
-32.00%-809.74M
-37.78%-345.51M
-62.54%-613.43M
---250.77M
-150.13%-377.41M
Revaluation surplus
----
-100.83%-7K
--5.12M
--848K
----
----
----
----
----
----
-Changes in the fair value of financial assets
----
-100.83%-7K
----
--848K
----
----
----
----
----
----
-Changes in the fair value of other assets
----
----
--5.12M
----
----
----
----
----
----
----
Special items of operating profit
116.23%58.81M
-308.25%-357.75M
-643.10%-362.29M
-107.63%-87.63M
-75.70%-48.75M
4,015.37%1.15B
-365.43%-27.75M
84,433.33%27.9M
---5.96M
-99.88%33K
Operating profit
60.61%-262.56M
-19.87%-1.12B
-39.19%-666.64M
-262.89%-931.89M
25.13%-478.93M
74.98%-256.8M
-57.45%-639.65M
-49.08%-1.03B
-406.26M
-290.92%-688.46M
Financing income
-62.69%12.77M
-13.69%73.02M
-37.49%34.23M
157.27%84.61M
1,075.59%54.76M
36.66%32.89M
---5.61M
175.86%24.07M
----
---31.73M
Financing cost
----
----
----
----
----
----
----
----
--26.52M
----
Special items of earning before tax
----
-5.92%2.65M
----
112.07%2.82M
102.43%554K
-262.09%-23.36M
-576.94%-22.78M
99.87%-6.45M
---3.37M
-13,446.16%-4.94B
Earning before tax
60.50%-249.79M
-23.32%-1.04B
-49.29%-632.41M
-241.51%-844.46M
36.59%-423.61M
75.49%-247.28M
-74.37%-668.04M
82.17%-1.01B
-383.11M
-2,537.69%-5.66B
Tax
----
----
----
----
----
---8K
----
----
----
----
After-tax profit from continuing operations
60.50%-249.79M
-23.32%-1.04B
-49.29%-632.41M
-241.50%-844.46M
36.59%-423.61M
75.49%-247.28M
-74.37%-668.04M
82.17%-1.01B
-383.11M
-2,537.69%-5.66B
Earning after tax
60.50%-249.79M
-23.32%-1.04B
-49.29%-632.41M
-241.50%-844.46M
36.59%-423.61M
75.49%-247.28M
-74.37%-668.04M
82.17%-1.01B
-383.11M
-2,537.69%-5.66B
Profit attributable to shareholders
60.50%-249.79M
-23.32%-1.04B
-49.29%-632.41M
-241.50%-844.46M
36.59%-423.61M
75.49%-247.28M
-74.37%-668.04M
82.17%-1.01B
-383.11M
-2,537.69%-5.66B
Basic earnings per share
60.91%-0.77
-20.00%-3.24
-40.71%-1.97
-225.30%-2.7
38.05%-1.4
75.87%-0.83
-72.52%-2.26
94.81%-3.44
-1.31
-61.53%-66.29
Diluted earnings per share
60.91%-0.77
-20.00%-3.24
-40.71%-1.97
-225.30%-2.7
38.05%-1.4
75.87%-0.83
-72.52%-2.26
94.81%-3.44
-1.31
-61.53%-66.29
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
Ernst & Young
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
(Q6)Jun 30, 2025(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020
Turnover 47.96%446.12M461.16%706.68M3,289.74%301.52M884.46%125.93M752.01%8.9M23,588.89%12.79M--1.04M--54K--------
Operating income 47.96%446.12M461.16%706.68M3,289.74%301.52M884.46%125.93M752.01%8.9M23,588.89%12.79M1.04M54K
Cost of sales -108.31%-146.73M-422.44%-179.79M-2,022.91%-70.44M-640.88%-34.41M-811.54%-3.32M-20,095.65%-4.65M---364K---23K--------
Operating expenses -108.31%-146.73M-422.44%-179.79M-2,022.91%-70.44M-640.88%-34.41M-811.54%-3.32M-20,095.65%-4.65M-364K-23K
Gross profit 29.56%299.4M475.72%526.88M4,043.43%231.08M1,023.33%91.52M720.15%5.58M26,180.65%8.15M680K31K
Selling expenses -57.07%-314.75M-119.55%-508.07M-212.48%-200.39M29.16%-231.42M56.72%-64.13M-64.87%-326.69M-251.94%-148.16M-496.01%-198.15M---42.1M---33.25M
Administrative expenses -27.35%-110.8M-51.42%-250.08M-4.65%-87M40.28%-165.16M30.09%-83.13M-13.96%-276.55M-10.69%-118.91M12.65%-242.68M---107.43M-415.93%-277.83M
Research and development expenses 22.89%-195.22M2.23%-528.04M12.25%-253.16M33.30%-540.05M16.50%-288.49M-32.00%-809.74M-37.78%-345.51M-62.54%-613.43M---250.77M-150.13%-377.41M
Revaluation surplus -----100.83%-7K--5.12M--848K------------------------
-Changes in the fair value of financial assets -----100.83%-7K------848K------------------------
-Changes in the fair value of other assets ----------5.12M----------------------------
Special items of operating profit 116.23%58.81M-308.25%-357.75M-643.10%-362.29M-107.63%-87.63M-75.70%-48.75M4,015.37%1.15B-365.43%-27.75M84,433.33%27.9M---5.96M-99.88%33K
Operating profit 60.61%-262.56M-19.87%-1.12B-39.19%-666.64M-262.89%-931.89M25.13%-478.93M74.98%-256.8M-57.45%-639.65M-49.08%-1.03B-406.26M-290.92%-688.46M
Financing income -62.69%12.77M-13.69%73.02M-37.49%34.23M157.27%84.61M1,075.59%54.76M36.66%32.89M---5.61M175.86%24.07M-------31.73M
Financing cost ----------------------------------26.52M----
Special items of earning before tax -----5.92%2.65M----112.07%2.82M102.43%554K-262.09%-23.36M-576.94%-22.78M99.87%-6.45M---3.37M-13,446.16%-4.94B
Earning before tax 60.50%-249.79M-23.32%-1.04B-49.29%-632.41M-241.51%-844.46M36.59%-423.61M75.49%-247.28M-74.37%-668.04M82.17%-1.01B-383.11M-2,537.69%-5.66B
Tax -----------------------8K----------------
After-tax profit from continuing operations 60.50%-249.79M-23.32%-1.04B-49.29%-632.41M-241.50%-844.46M36.59%-423.61M75.49%-247.28M-74.37%-668.04M82.17%-1.01B-383.11M-2,537.69%-5.66B
Earning after tax 60.50%-249.79M-23.32%-1.04B-49.29%-632.41M-241.50%-844.46M36.59%-423.61M75.49%-247.28M-74.37%-668.04M82.17%-1.01B-383.11M-2,537.69%-5.66B
Profit attributable to shareholders 60.50%-249.79M-23.32%-1.04B-49.29%-632.41M-241.50%-844.46M36.59%-423.61M75.49%-247.28M-74.37%-668.04M82.17%-1.01B-383.11M-2,537.69%-5.66B
Basic earnings per share 60.91%-0.77-20.00%-3.24-40.71%-1.97-225.30%-2.738.05%-1.475.87%-0.83-72.52%-2.2694.81%-3.44-1.31-61.53%-66.29
Diluted earnings per share 60.91%-0.77-20.00%-3.24-40.71%-1.97-225.30%-2.738.05%-1.475.87%-0.83-72.52%-2.2694.81%-3.44-1.31-61.53%-66.29
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor --Ernst & Young--PricewaterhouseCoopers--PricewaterhouseCoopers--PricewaterhouseCoopers--PricewaterhouseCoopers

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
View More
New Consumption Stocks
View More
Hong Kong stocks continue to recover! The Hang Seng Index briefly returned to 26,000 points.
Recently, Hong Kong stocks have rebounded from their lows, with the three major indices continuing their upward momentum. The Hang Seng Inde Show More